<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Christoph</forename><surname>Kowalski</surname></persName>
							<email>kowalski@krebsgesellschaft.de</email>
							<idno type="ORCID">0000-0002-7438-4321</idno>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ullrich</forename><surname>Graeven</surname></persName>
							<idno type="ORCID">0000-0002-7438-4321</idno>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christof</forename><surname>Von Kalle</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hauke</forename><surname>Lang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Matthias</forename><forename type="middle">W</forename><surname>Beckmann</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jens-Uwe</forename><surname>Blohmer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Martin</forename><surname>Burchardt</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Ehrenfeld</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jan</forename><surname>Fichtner</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephan</forename><surname>Grabbe</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hans</forename><surname>Hoffmann</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Heinrich</forename><surname>Iro</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stefan</forename><surname>Post</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anton</forename><surname>Scharl</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Uwe</forename><surname>Schlegel</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><surname>Seufferlein</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Walter</forename><surname>Stummer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dieter</forename><surname>Ukena</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Julia</forename><surname>Ferencz</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Simone</forename><surname>Wesselmann</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">German Cancer Society</orgName>
								<orgName type="department" key="dep2">Department for Certification</orgName>
								<address>
									<addrLine>Kuno-Fischer-Strasse 8</addrLine>
									<postCode>14057</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">F227AB410ABE9FF178FDB6C72FDA124E</idno>
					<idno type="DOI">10.1186/s12885-017-3824-1</idno>
					<note type="submission">Received: 25 September 2017 Accepted: 23 November 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:46+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Multidisciplinarity</term>
					<term>Certification</term>
					<term>Quality of care</term>
					<term>Quality indicators</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Over the last decades numerous initiatives have been set up that aim at translating the best available medical knowledge and treatment into clinical practice.</s><s>The inherent complexity of the programs and discrepancies in the terminology used make it difficult to appreciate each of them distinctly and compare their specific strengths and weaknesses.</s><s>To allow comparison and stimulate dialogue between different programs, we in this paper provide an overview of the German Cancer Society certification program for multidisciplinary cancer centers that was established in 2003.</s></p><p><s>Main body: In the early 2000s the German Cancer Society assessed the available information on quality of cancer care in Germany and concluded that there was a definite need for a comprehensive, transparent and evidencebased system of quality assessment and control.</s><s>This prompted the development and implementation of a voluntary cancer center certification program that was promoted by scientific societies, health-care providers, and patient advocacy groups and based on guidelines of the highest quality level (S3).</s><s>The certification system structures the entire process of care from prevention to screening and multidisciplinary treatment of cancer and places multidisciplinary teams at the heart of this program.</s><s>Within each network of providers, the quality of care is documented using tumor-specific quality indicators.</s><s>The system started with breast cancer centers in 2003 and colorectal cancer centers in 2006.</s><s>In 2017, certification systems are established for the majority of cancers.</s><s>Here we describe the rationale behind the certification program, its history, the development of the certification requirements, the process of data collection, and the certification process as an example for the successful implementation of a voluntary but powerful system to ensure and improve quality of cancer care.</s><s>Conclusion: Since 2003, over 1 million patients had their primary tumors treated in a certified center.</s><s>There are now over 1200 sites for different tumor entities in four countries that have been certified in accordance with the program and transparently report their results from multidisciplinary treatment for a substantial proportion of cancers.</s><s>This led to a fundamental change in the structure of cancer care in Germany and neighboring countries within one decade.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>In addition to breakthroughs that have been made in the diagnosis and treatment of cancers, considerable effort over the last 20 years has been put into ensuring that the state of the art of care is translated into everyday care for the entire population in need.</s><s>Indeed, this issue is at the heart of the debate about the quality of cancer care and how to improve it <ref type="bibr" target="#b3">[1]</ref><ref type="bibr" target="#b4">[2]</ref><ref type="bibr" target="#b5">[3]</ref><ref type="bibr" target="#b6">[4]</ref><ref type="bibr" target="#b7">[5]</ref>.</s><s>Numerous campaigns have been initiated that aim at translating the best available medical knowledge and treatment into clinical practice.</s><s>They typically define standards for how to measure, compare, and improve the quality of care and how to best incorporate multidisciplinarity <ref type="bibr" target="#b8">[6]</ref><ref type="bibr" target="#b9">[7]</ref><ref type="bibr" target="#b10">[8]</ref><ref type="bibr" target="#b11">[9]</ref><ref type="bibr" target="#b12">[10]</ref><ref type="bibr" target="#b13">[11]</ref><ref type="bibr" target="#b14">[12]</ref>.</s></p><p><s>Some initiatives have also developed certification and accreditation programs for quality assurance and quality development using rigorous data collection processes, quality indicators, on-site auditing and peer review.</s><s>These campaigns are partly government-driven, but most have been initiated by professional associations <ref type="bibr" target="#b14">[12]</ref><ref type="bibr">[13]</ref><ref type="bibr" target="#b16">[14]</ref><ref type="bibr" target="#b17">[15]</ref><ref type="bibr" target="#b18">[16]</ref>.</s><s>The inherent complexity of the programs and discrepancies in the terminology used make it difficult to appreciate each of them distinctly and compare their specific strengths and weaknesses.</s><s>To allow comparison and stimulate dialogue between different programs, we describe here the certification system organized by the German Cancer Society (Deutsche Krebsgesellschaft, DKG).</s><s>We explain the rationale for the certification program, the development of the certification requirements, the process of data collection, and the certification process.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Rationale and brief history of the program</head><p><s>In the early 2000s, analyses of the limited data available suggested that despite enormous financial resources the results regarding cancer survival in Germany were only moderate compared to the results obtained in other European countries <ref type="bibr" target="#b19">[17]</ref>.</s><s>This resulted in several initiatives aimed at improving care, such as the development of clinical guidelines of the highest quality level for the most frequent cancer entities and a novel Cancer Center Certification Program by the DKG.</s><s>This program was initially introduced for breast cancer following the example of the EUSOMA effort (European Society of Breast Cancer Specialists, <ref type="bibr" target="#b16">[14,</ref><ref type="bibr" target="#b20">18]</ref>) and soon afterwards also for other types of cancer.</s><s>The program was intended to put evidence-based guideline recommendations into practice in everyday care and to place multidisciplinary teams at the heart of the cancer care process.</s><s>To ensure that evidence-based standards are met in the certified units an auditing system based on quality metrics was implemented.</s><s>The Cancer Center Certification Program was originally initiated, and has since been continually developed, by the professional associations involved in cancer care, working groups, and patient advocacy groups.</s><s>Participation in the certification system is voluntary.</s><s>This means that there is no official (government) body that requests certification in order to be able to provide a particular cancer service, and the government is not involved in defining the criteria for certification.</s></p><p><s>The centers established within the DKG certification system are tumor-specific networks (for an overview of the various types of center, see Fig. <ref type="figure">1</ref>) in which patients are treated in a comprehensive, interdisciplinary, and multi-professional manner.</s><s>Disciplines that are essential for the treatment of a particular cancer are specifically defined for each type of center.</s><s>In breast cancer centers for example these teams comprise gynecologists, radiologists, pathologists, medical oncologists, radiotherapists, and specialists in nuclear medicine (termed "main cooperation partners").</s><s>In addition, written agreements for on request services have to be made with representatives of the following fields: oncological nursing, psychooncology, hospice/palliative medicine, social services, patient advocacy groups, genetic counseling, physiotherapy, laboratory medicine, and supplier of medical products <ref type="bibr" target="#b21">[19]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Development of the DKG cancer centers in Germany</head><p><s>Shortly after the publication of the first Eurocare results <ref type="bibr" target="#b19">[17]</ref>, the DKG and the German Society for Breast A Comprehensive Cancer Center (CCC) is a leading oncology center with major research aims.</s><s>Specifically for rarercancers and special issues An Oncology Center extends to several organs or specialties, particularly for less common cancers such as neurological, head and neck, pancreatic, liver, and stomach cancer An Organ Cancer Center is a center specializing in one organ or specialty (breast, colorectal, lung, prostate, skin, gynecological tumors) Fig. <ref type="figure">1</ref> The three-tier model of certified cancer centers Diseases (Deutsche Gesellschaft für Senologie, DGS) established the first set of criteria for certified cancer centers in accordance with the national clinical guidelines for breast cancer <ref type="bibr" target="#b23">[20]</ref>.</s><s>Subsequently, colorectal cancer centers (2006), skin cancer centers, gynecological cancer centers, lung cancer centers, and prostate cancer centers (all in 2008) were added to the certification program, each following guidelines of the highest quality level for the respective cancer entity.</s><s>Each program has overlapping, general standards but also contains a set of distinct, cancer-specific requirements.</s><s>Some of these requirements are translated into quality metrics that allow for comparisons across the different sites all over the country.</s><s>The centers cover the whole spectrum of care for the respective tumor including prevention, early detection, treatment of the primary and advanced tumors, supportive and palliative care as well as psychooncology, social support and self-help groups.</s><s>The DKG program operates as part of the German National Cancer Plan led by the German Ministry of Health <ref type="bibr">[21]</ref>, that laid down a three-tier model of cancer centers in Germany consisting of Organ Cancer Centers (C), Oncology Centers (CC), and Comprehensive Cancer Centers (CCC, funded by the German Cancer Aid) (Fig. <ref type="figure">1</ref>) <ref type="bibr" target="#b24">[22]</ref>.</s><s>Patient care must meet the same quality requirements in all aspects irrespectively of the institution and of its position in the three-tier model of the National Cancer Certification Program <ref type="bibr" target="#b25">[23]</ref>.</s></p><p><s>As of January 2017, there are 1200 certified Organ Cancer Centers, 109 Oncology Centers, and 15 Comprehensive Cancer Centers in Germany.</s><s>Fig 2 demonstrates that this still entirely voluntary program is continuously growing.</s><s>By now, approximately 40% of the population in Germany with primary cancers for which centers have been established are treated in certified institutions (Table <ref type="table" target="#tab_0">1</ref>).</s><s>The geographic distribution of centers is illustrated in Fig. <ref type="figure">3</ref>. Sixty sites are currently located in countries neighboring Germany -Italy, Switzerland, and Austria.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Certification: Structure, standards, and fulfillment</head><p><s>To provide the greatest possible degree of professional independence for those who develop and review the requirements and their implementation, and to avoid individual conflicts of interest, the certification system is Fig. <ref type="figure">3</ref> The distribution of centers in Germany divided into three branches that work independently of each other (Fig. <ref type="figure">4</ref> "Separation of Powers").</s><s>Each cancer-specific Certification Committee consists of 30-40 experts of all specialties and professional groups involved that have been delegated by their respective professional medical society, by scientific societies, working groups, and self-help organizations.</s><s>The Certification Committees convene annually or biennially to discuss the results from the certified centers and ensure timely updates of the requirements specification.</s></p><p><s>2. Audit and data evaluation (corresponding to an "executive" body): To obtain the certificate for a specific cancer center the applicants must comply with the standards set out in the requirements specification developed by the relevant Certification Committee of the DKG.</s><s>Data on the requirements are documented by each center using an electronic reporting system.</s><s>Data are then reported to an independent certification institute, OnkoZert, where the documentation is formally checked for completeness and plausibility.</s><s>To assure independence, OnkoZert manages the documents, organizes the audits and commissions the auditors but cannot influence the decision of awarding the certificate.</s><s>Specially trained oncological medical experts from various specialties including surgery, pathology, gastroenterology, medical oncology, gynecology (i.e., the auditors) verify the implementation of the requirements and the validity of the documentation.</s><s>Verification of the implementation of the requirements is done during an on-site audit of the documentation, of structures and processes at the centers.</s><s>During these audits, the auditors examine actual patient files and discuss the results with the centers at the end of the site visit.</s><s>The auditors prepare a written report about the data and the on-site visit.</s><s>If any non-compliance with the certification requirements is observed during the audit, the auditor pronounces a so-called "deviation".</s><s>The center then has three months to remedy this deviation starting from the audit day.</s></p><p><s>Positive remedying is the precondition for the award of the certificate.</s><s>The auditors include a recommendation about the award of a certificate in their report.</s><s>If the center fails to remedy a deviation, the auditor will recommend to not issue the certificate.</s><s>Auditors must not be members of the Certification Committee.</s><s>3. Certificate Award Committee (corresponding to "jurisdiction"): The final decision whether to award or deny a certificate is taken by another independent body, the Certificate Award Committee.</s><s>This committee consists of three medical experts who are not involved in the corresponding audit.</s><s>The Committee awards or denies the certificates based on the audit report and the auditors' recommendations.</s><s>In 2016, 117 new certificates have been awarded and 14 certificates have been withdrawn because of not sufficient audit results.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data reporting</head><p><s>All data from the tumor documentation of the respective centers are submitted electronically to the independent certification institute OnkoZert.</s><s>Here, a software called</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Certification commission</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Catalogue of requirements</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Legislative</head><p><s>Auditors/ OnkoZert</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Audit</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Executive</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Certificate award committee</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Certificate</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Judiciary</head><p><s>Fig. <ref type="figure">4</ref> The separation of powers in the certification system OncoBox that can interact with and extract data from the tumor documentation softwares used in Germany, runs a plausibility check of the data and calculates the quality indicators.</s><s>Discrepancies are fed back to the centers for clearance.</s><s>Cancer type and also center-specific results regarding the quality indicators are presented to the public in annual reports (e.g., <ref type="bibr" target="#b27">[25]</ref>) and in scientific journals (e.g., <ref type="bibr" target="#b23">[20,</ref><ref type="bibr" target="#b28">26,</ref><ref type="bibr" target="#b29">27]</ref>).</s><s>Some of the requirements and quality indicators are the same for all center types and tumor entities, such as a study participation rate of 5% of patients, delivery of social services and psychooncological counseling to all patients, and of all patients in specific multidisciplinary boards.</s><s>However, most of the requirements are tailored to the specific center/tumor.</s><s>As an example, one tumor-specific quality indicator for each center type is listed in Table <ref type="table" target="#tab_2">2</ref>.</s><s>The quality indicators presented in the Table are derived from the clinical guidelines, unless otherwise indicated, and are part of the annual reports.</s></p><p><s>With the number of DKG certified centers outside Germany constantly increasing, the German Cancer Society's certification system has now become the largest in Europe.</s><s>This provides many opportunities, including the ability to compare the quality of care not only within different regions of one country, but also across countries.</s><s>Smaller countries with only a few centers, which would otherwise lack an appropriate comparator, can match their results with many centers from different countries and evaluate their development over time.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acquiring the certificate: The center perspective</head><p><s>The certification criteria are outlined on the website of the independent certification institute OnkoZert (www.onkozert.de).</s><s>Once a center has decided to apply for its initial certificate, it submits an inquiry form 3 to 6 months prior to the projected audit date.</s><s>The inquiry form is reviewed by OnkoZert and a judgement is made on whether the center is in principle suitable for certification or whether its current structures make certification impossible.</s><s>It is recommended that the centers then submit the necessary data 2 months prior to the audit date.</s><s>The documents are formally reviewed and passed on to the responsible auditor(s), who provide(s) a written assessment about the contents.</s><s>This assessment is then sent to the centers so that they can use it to make final adjustments regarding structures and processes.</s><s>The subsequent on-site audit takes one or two days, depending on the type of audit, and includes auditing of all departments that shall participate in the certified center as well as of external cooperation partners.</s><s>Relevant documents such as patient charts are reviewed on site and compared with the data submitted.</s><s>Discrepancies between the actual situation and the certification criteria must be corrected within 3 months after the audit and are then re-evaluated by the auditor on paper or on site, depending on the specific issue.</s><s>The auditor submits the audit report to OnkoZert, which verifies the data, and passes the audit report on to the Certificate Award Committee.</s><s>Finally, the latter decides on denying or awarding of the certificate, which is then valid for 3 years.</s><s>Full reevaluation-audits take place every 3 years, and surveillance auditsi.e., shorter audits focusing on the results for key figures and quality indicators are performed every year.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>The DKG Cancer Center Certification program is a unique program: It is entirely voluntary, covers the most relevant tumor entities in a steadily increasing proportion, is based on guidelines of the highest quality, is run by experts in the field independent of governmental influence and comprises the whole spectrum of cancer care from prevention to screening, multidisciplinary treatment, social and psychooncological, supportive and palliative care.</s><s>By implementing guidelines of the highest quality and the best available medical knowledge into everyday care it aims at comprehensively improving the quality of cancer care across all relevant tumor entities and across all regions.</s><s>An important goal of the program is to also make quality of care transparent across all sites and thereby allowing to compare the centers based on The certification program has led to several paradigm shifts in Germany.</s><s>Only three shall be outlined here.</s><s>First and foremost, multidisciplinarity in cancer care has become widely established and is not limited to the multidisciplinary tumor boards.</s><s>This is a development that would not have been foreseeable 15 years ago.</s><s>The way in which the individual patient is treated no longer depends on one clinician alone, but includes expertise from the relevant providers within the network, who are specified by name.</s><s>This multidisciplinary approach is not limited to medical specialties, but also includes psycho-social care <ref type="bibr" target="#b30">[28]</ref> as well as nursing and palliative care, to which every patient is entitled.</s><s>Secondly, the "separation of powers" in the certification system facilitates fair processes for the development and evaluation of requirements and for awarding certificates.</s><s>Specific professional groups cannot play a dominant role.</s><s>Thirdly, the collection and reporting of quality-of-care data that are implemented throughout the certification program <ref type="bibr" target="#b29">[27]</ref>, makes provider evaluation indicator-based and allows to compare the results and enables mutual learning.</s><s>Indeed, due to the success of this program, comparisons are not limited to one country, but also include centers in other countries including Switzerland, Austria, and Italy.</s><s>This provides an opportunity to make the quality of cancer care comparable on a European scale and to expand collaborations on this topic between scientific societies in different countries.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 2</head><label>2</label><figDesc><div><p><s>Fig. 2 Numbers of center sites, 2003-2016</s></p></div></figDesc><graphic coords="3,127.28,94.85,340.76,261.75" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Current status of the certification system</s></p></div></figDesc><table><row><cell></cell><cell cols="3">Organ cancer centers</cell><cell></cell><cell></cell><cell></cell><cell>Modules</cell><cell></cell><cell></cell><cell>Oncology</cell><cell>Comprehensive</cell></row><row><cell></cell><cell cols="4">Breast Colorectal Gynecological Skin</cell><cell cols="2">Lung Prostate</cell><cell>Head/neck</cell><cell>CNS</cell><cell>Pancreas</cell><cell>centers</cell><cell>cancer centers</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>tumors</cell><cell>tumors</cell><cell></cell><cell></cell></row><row><cell>Current first</cell><cell>4</cell><cell>7</cell><cell>6</cell><cell>5</cell><cell>5</cell><cell>7</cell><cell>6</cell><cell>8</cell><cell>5</cell><cell>6</cell></row><row><cell>certification</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Certified center</cell><cell>230</cell><cell>280</cell><cell>133</cell><cell>55</cell><cell>45</cell><cell>103</cell><cell>41</cell><cell>26</cell><cell>91</cell><cell>97</cell></row><row><cell cols="2">Certified center sites 280</cell><cell>288</cell><cell>135</cell><cell>55</cell><cell>53</cell><cell>104</cell><cell>43</cell><cell>27</cell><cell>93</cell><cell>109</cell><cell>15</cell></row><row><cell cols="3">Primary cases, 2015 54,230 26,660</cell><cell>12,306</cell><cell cols="3">11,209 b 17,731 19,932</cell><cell>6273 c</cell><cell cols="2">5456 d 4070</cell><cell>35,670</cell></row><row><cell>New cases of cancer a</cell><cell cols="2">70,170 62,230</cell><cell>26,140</cell><cell>20,820 b</cell><cell cols="2">52,520 63,710</cell><cell>15,628 c</cell><cell>-</cell><cell>16,730</cell><cell>-</cell></row><row><cell>Total share e</cell><cell cols="2">74.6% 41.4%</cell><cell>43.6%</cell><cell cols="3">50.8% 32.9% 29.6%</cell><cell>37.5%</cell><cell>-</cell><cell>22.9%</cell><cell>-</cell></row><row><cell cols="2">Center sites abroad 11</cell><cell>10</cell><cell>9</cell><cell>4</cell><cell>2</cell><cell>7</cell><cell>4</cell><cell>1</cell><cell>6</cell><cell>6</cell></row></table><note><p><s>CNS, central nervous system a Based on German registry data from 2012 b Only includes malignant melanoma c New cases of head and neck tumor: mouth and pharynx ICD-10 C00-C06, C09-C14, larynx C32 d Neuroendocrine tumors (C70-C75, in the International Classification of Diseases for Oncology, ICD-O) eNumerator: primary patients from centers in Germany, denominator: primary cases in Germany As of: 31 December 2016, does not include data on the two most recently added modules (liver, stomach)</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2</head><label>2</label><figDesc><div><p><s>Example quality indicators for each center/module type</s></p></div></figDesc><table><row><cell>Center/</cell><cell>Quality indicator definition</cell><cell>Target value</cell><cell>Sites meeting the</cell><cell>Median</cell><cell>Source</cell></row><row><cell>module</cell><cell></cell><cell></cell><cell>target in 2015</cell><cell></cell><cell></cell></row><row><cell>Breast</cell><cell>Pretreatment histological confirmation</cell><cell>≥ 90%</cell><cell>97.5% (268/275)</cell><cell>97.6%</cell><cell>Annual Report of Certified Breast</cell></row><row><cell></cell><cell>(numerator: patients with pretreatment</cell><cell></cell><cell></cell><cell></cell><cell>Cancer Centers 2016 -Quality</cell></row><row><cell></cell><cell>histological diagnosis confirmation by</cell><cell></cell><cell></cell><cell></cell><cell>Indicators (in English)</cell></row><row><cell></cell><cell>means of a punch or vacuum biopsy;</cell><cell></cell><cell></cell><cell></cell><cell>doi:10.13140/RG.2.1.1805.7204</cell></row><row><cell></cell><cell>population: patients with initial procedure</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>and histology showing invasive breast</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>cancer or DCIS as primary disease)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Colorectal Quality of the TME rectum specimen</cell><cell>≥ 70%</cell><cell>98.5% (257/261)</cell><cell>95.2%</cell><cell>Annual Report of Certified Colorectal</cell></row><row><cell></cell><cell>(information from pathology; numerator:</cell><cell></cell><cell></cell><cell></cell><cell>Cancer Centers 2016 -Quality</cell></row><row><cell></cell><cell>patients with good to moderate quality</cell><cell></cell><cell></cell><cell></cell><cell>Indicators (in English)</cell></row><row><cell></cell><cell>TME [grade 1: mesorectal fascia or grade 2:</cell><cell></cell><cell></cell><cell></cell><cell>doi:10.13140/RG.2.1.3771.8001</cell></row><row><cell></cell><cell>intramesorectal excisions]; population:</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>patients with radically operated rectal</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>cancer)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Prostate</cell><cell>Percutaneous radiotherapy with hormone</cell><cell>No target in</cell><cell>-</cell><cell>71.43%</cell><cell>Annual Report of Certified Prostate</cell></row><row><cell></cell><cell>ablation therapy for locally confined</cell><cell>2015</cell><cell></cell><cell>(93 sites)</cell><cell>Cancer Centers 2016 -Quality</cell></row><row><cell></cell><cell>prostate carcinoma with high risk</cell><cell></cell><cell></cell><cell></cell><cell>Indicators (in English)</cell></row><row><cell></cell><cell>(numerator: primary cases with additional</cell><cell></cell><cell></cell><cell></cell><cell>doi:10.13140/RG.2.1.3673.4969</cell></row><row><cell></cell><cell>neoadjuvant and/or adjuvant hormone</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>ablation therapy; population: primary cases</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>with prostate carcinoma T1-2 N0 M0 with</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>high risk (PSA &gt; 20 ng/mL or Gleason</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>score ≥ 8 or clinical stage T2c) and</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>percutaneous radiotherapy</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Lung</cell><cell>Combined chemoradiotherapy in stage</cell><cell>No target in</cell><cell>-</cell><cell>39.6%</cell><cell>Annual Report of Certified Lung</cell></row><row><cell></cell><cell>IIIA4/IIIB (numerator: combined</cell><cell>2015</cell><cell></cell><cell></cell><cell>Cancer Centers 2016 -Quality</cell></row><row><cell></cell><cell>chemoradiotherapy in NSCLC primary cases</cell><cell></cell><cell></cell><cell></cell><cell>Indicators (in German)</cell></row><row><cell></cell><cell>in stage IIIA4/IIIB with ECOG 0/1; population:</cell><cell></cell><cell></cell><cell></cell><cell>doi:10.13140/RG.2.1.3998.6327</cell></row><row><cell></cell><cell>NSCLC primary cases in stage IIIA4/IIIB</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Skin</cell><cell>Malignant melanoma: sentinel-node biopsy</cell><cell>≥ 80%</cell><cell>72.7% (32/44)</cell><cell>85.2%</cell><cell>Annual Report of Certified Skin</cell></row><row><cell></cell><cell>(SNB, numerator: primary cases in which</cell><cell></cell><cell></cell><cell></cell><cell>Cancer Centers 2016 -Quality</cell></row><row><cell></cell><cell>SNB was carried out; population: primary</cell><cell></cell><cell></cell><cell></cell><cell>Indicators (in German)</cell></row><row><cell></cell><cell>cases of primary cutaneous melanoma with</cell><cell></cell><cell></cell><cell></cell><cell>doi:10.13140/RG.2.1.2227.2408</cell></row><row><cell></cell><cell>a tumor thickness of ≥1 mm and no evi-</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>dence of locoregional or distant metastasis)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Ovary</cell><cell>Postoperative chemotherapy for advanced</cell><cell>No target in</cell><cell>-</cell><cell>96.4%</cell><cell>Annual Report of Certified</cell></row><row><cell></cell><cell>ovarian carcinoma (numerator: primary</cell><cell>2015</cell><cell></cell><cell></cell><cell>Gynecological Cancer Centers 2016</cell></row><row><cell></cell><cell>surgical cases of FIGO IIB-IV ovarian</cell><cell></cell><cell></cell><cell></cell><cell>-Quality Indicators (in German)</cell></row><row><cell></cell><cell>carcinoma with postoperative</cell><cell></cell><cell></cell><cell></cell><cell>doi:10.13140/RG.2.1.1052.0568</cell></row><row><cell></cell><cell>chemotherapy; population: primary surgical</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>cases of FIGO IIB-IV ovarian carcinoma and</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>chemotherapy)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Cervix</cell><cell>Histological confirmation</cell><cell>No target in</cell><cell>-</cell><cell>100.0%</cell><cell>Annual Report of Certified</cell></row><row><cell></cell><cell></cell><cell>2015</cell><cell></cell><cell></cell><cell>Gynecological Cancer Centers 2016</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>-Quality Indicators (in German)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>doi:10.13140/RG.2.1.1052.0568</cell></row><row><cell>Head-</cell><cell>Imaging in patients with oral cavity</cell><cell>No target in</cell><cell>-</cell><cell>91.7%</cell><cell>Annual Report of Certified Head and</cell></row><row><cell>neck</cell><cell>carcinoma to determine N category</cell><cell>2015</cell><cell></cell><cell></cell><cell>Neck Tumor Centers 2016 -Quality</cell></row><row><cell></cell><cell>(numerator: patients with CT or MRI</cell><cell></cell><cell></cell><cell></cell><cell>Indicators (in German)</cell></row><row><cell></cell><cell>examinations of the region from the cranial</cell><cell></cell><cell></cell><cell></cell><cell>doi:10.13140/RG.2.1.2788.7609</cell></row><row><cell></cell><cell>base to the superior thoracic aperture to</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>determine the N category; population:</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>primary cases of patients with oral cavity</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>carcinoma)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>CNS</cell><cell>Interdisciplinary case discussions (numerator:</cell><cell>≥ 95%</cell><cell>68.4% (13/19)</cell><cell>96.4%</cell><cell>Annual Report of Certified Neuro-</cell></row><row><cell>tumors</cell><cell>primary cases [elective patients: pre-</cell><cell></cell><cell></cell><cell></cell><cell>Oncological Tumor Centers 2016 -</cell></row><row><cell></cell><cell>interventional, emergency patients: post-</cell><cell></cell><cell></cell><cell></cell><cell>Quality Indicators (in German)</cell></row><row><cell></cell><cell>interventional] presented at the tumor con-</cell><cell></cell><cell></cell><cell></cell><cell>doi:10.13140/RG.2.1.2788.7609</cell></row><row><cell></cell><cell>ference; population: primary cases), indicator</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>not derived from clinical guidelines</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2</head><label>2</label><figDesc><div><p><s>Example quality indicators for each center/module type (Continued) CT, computed tomography; DCIS, ductal carcinoma in situ; DOI, digital object identifier; FIGO, Fédération Internationale de Gynécologie et d'Obstetrique; ICD, International Statistical Classification of Diseases and Health-Related Problems, 10th Revision; MRI, magnetic resonance imaging; NSCLC, non-small cell lung cancer; PSA, prostate-specific antigen; TME, total mesorectal excision objective indicators.</s><s>This shall in turn stimulate mutual learning among the participating certified units.</s></p></div></figDesc><table><row><cell>Center/</cell><cell>Quality indicator definition</cell><cell>Target value</cell><cell>Sites meeting the</cell><cell>Median</cell><cell>Source</cell></row><row><cell>module</cell><cell></cell><cell></cell><cell>target in 2015</cell><cell></cell><cell></cell></row><row><cell cols="2">Pancreas Lymph-node examination (numerator:</cell><cell>No target value</cell><cell>-</cell><cell>90.0%</cell><cell>Annual Report of Certified Neuro-</cell></row><row><cell></cell><cell>primary surgical cases of pancreas with ≥10</cell><cell>in 2015</cell><cell></cell><cell></cell><cell>Oncological Tumor Centers 2016 -</cell></row><row><cell></cell><cell>regional lymph nodes in the surgical</cell><cell></cell><cell></cell><cell></cell><cell>Quality Indicators (in German)</cell></row><row><cell></cell><cell>specimen after completion of surgical</cell><cell></cell><cell></cell><cell></cell><cell>doi:10.13140/RG.2.1.2788.7609</cell></row><row><cell></cell><cell>treatment; population: primary surgical cases</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>in pancreas (OPS 5-524 ff., 5-525 ff. only</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>with ICD-10 C25) who have undergone</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>lymphadenectomy)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>Not applicable.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Availability of data and materials</head><p><s>Not applicable, i.e. the raw data are not publicly available.</s><s>However, the numbers presented in Tables <ref type="table">1 and 2</ref> are taken from the respective annual reports as referred to in Table <ref type="table">2</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authors' contributions</head><p><s>CK and SW drafted the first version of the manuscript, JF interpreted the data and developed the tables and figures.</s><s>All authors contributed in writing to the manuscript during several rounds of discussion.</s><s>All authors read and approved the final manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics approval and consent to participate</head><p><s>Not applicable, i.e., the study involves no human participants, human data or human tissue but only aggregated quality assurance information.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Consent for publication</head><p><s>Not applicable, i.e. the report does not involve individual person's data.</s></p><p><s>Competing interests SW and CK are employees of the German Cancer Society and JF is an employee of the certification institute OnkoZert.</s><s>All other authors are chairpersons or deputy chairs of one of the cancer type-specific certification committees or of the oncology centers certification committee as well as heads of certified centers.</s><s>Many of the authors received research funding or hold other financial relationships with (pharmaceutical) companies that are not in conflict with the work presented here.</s><s>A full list will be provided by the corresponding author upon request.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Publisher's Note</head><p><s>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">German Cancer Society, Department for Certification</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">14057</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">University Hospital, Langenbeckstrasse 1, 55131 Mainz, Germany. 5 University Hospital, Universitätsstrasse 21-23, 91054 Erlangen, Germany. 6 Charité University Hospital</title>
		<author>
			<persName><forename type="first">Germany</forename><surname>Berlin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">University Medical Center, Theodor-Kutzer-Ufer</title>
		<imprint>
			<biblScope unit="volume">450</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">69120</biblScope>
			<date>10117. 1-3, 68167</date>
		</imprint>
		<respStmt>
			<orgName>NCT University Hospital ; 10 University Hospital</orgName>
		</respStmt>
	</monogr>
	<note>Im Neuenheimer Feld. 12 Klinikum St. Marien, Mariahilfbergweg 7, 92224 Amberg</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">16 Hospital Ost, Züricher Strasse 40, 28325 Bremen, Germany. 17 OnkoZert GmbH, Certification Institute of the German Cancer Society</title>
		<author>
			<persName><forename type="first">Dept</forename><surname>Knappschaftskrankenhaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ruhr-University</forename><surname>Neurology</surname></persName>
		</author>
		<author>
			<persName><surname>Bochum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">der Schornau 23</title>
				<meeting><address><addrLine>Bochum, Germany; Ulm, Germany; Albert-Schweitzer-Campus 1, 48149 Münster, Germany; Neu-Ulm; Germany</addrLine></address></meeting>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page">89081</biblScope>
		</imprint>
	</monogr>
	<note>14 Ulm University Hospital, Albert-Einstein-Allee 23</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Quality of cancer care</title>
		<author>
			<persName><forename type="first">J</forename><surname>Vardy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">F</forename><surname>Tannock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Oncol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1001" to="1006" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title level="m" type="main">Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis</title>
		<editor>Levit L, Balogh E, Nass S, Ganz PA</editor>
		<imprint>
			<date type="published" when="2013">2013</date>
			<publisher>National Academies Press</publisher>
			<pubPlace>Washington (DC</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Institute of Medicine</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Identifying critical steps towards improved access to innovation in cancer care: a European CanCer organisation position paper</title>
		<author>
			<persName><forename type="first">M</forename><surname>Aapro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Astier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Audisio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Banks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bedossa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Brain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cameron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Casali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chiti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Mattos-Arruda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cancer</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="193" to="202" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Policy statement on multidisciplinary cancer care</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Borras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Albreht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Audisio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Briers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Casali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Esperou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Grube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hamoir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Henning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kelly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cancer</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="475" to="480" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">European breast cancer conference manifesto on breast centres/units</title>
		<author>
			<persName><forename type="first">F</forename><surname>Cardoso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cataliotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Knox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Marotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rutgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beishon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cancer</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="244" to="250" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Quality assurance and quality control for radiotherapy/medical oncology in Europe: guideline development and implementation</title>
		<author>
			<persName><forename type="first">V</forename><surname>Valentini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Glimelius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Frascino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Surg Oncol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="938" to="944" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Quality assurance in the treatment of colorectal cancer: the EURECCA initiative</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Breugom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Boelens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cbm</forename><surname>Van Den Broek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cervantes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Van Cutsem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Schmoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Valentini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cjh</forename><surname>Van De Velde</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Oncol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1485" to="1492" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Defining a standard set of patientcentered outcomes for men with localized prostate cancer</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Massey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stowell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bangma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Briganti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bill-Axelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Blute</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Catto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>'amico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Urol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="460" to="467" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper</title>
		<author>
			<persName><forename type="first">V</forename><surname>Valentini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P-A</forename><surname>Abrahamsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Aranda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Astier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Audisio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Boniol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bonomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brunelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bultz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chiti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">annals of oncology</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1863" to="1865" />
			<date type="published" when="2014">2014. 2014</date>
		</imprint>
	</monogr>
	<note>Ann Oncol</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Multidisciplinary team working across different tumour types: analysis of a national survey</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Lamb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sevdalis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Green</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Oncol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1293" to="1300" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">ECCO essential requirements for quality cancer care: colorectal cancer. A critical review</title>
		<author>
			<persName><forename type="first">G</forename><surname>Beets</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sebag-Montefiore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Andritsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beishon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Crul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Dekker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Delgado-Bolton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-F</forename><surname>Fléjou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Grisold</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Rev Oncol Hematol</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="81" to="93" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">The requirements of a specialist prostate cancer unit: a discussion paper from the European School of Oncology</title>
		<author>
			<persName><forename type="first">R</forename><surname>Valdagni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Albers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bangma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Drudge-Coates</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Magnani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Moynihan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Redmond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Sternberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Denis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Cancer</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Pioneering quality assessment in European cancer centers: a data analysis of the organization for European cancer institutes accreditation and designation program</title>
		<author>
			<persName><forename type="first">M</forename><surname>Saghatchian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Thonon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Boomsma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hummel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Koot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rajan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>De Valeriola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Otter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Laranja</forename><surname>Pontes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Oncol Pract</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="e342" to="349" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">EUSOMA: Position Paper. The requirements of a specialist breast unit</title>
	</analytic>
	<monogr>
		<title level="j">Eur J Cancer</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="2288" to="2293" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title level="m" type="main">American College of Surgeons: National Accreditation Program for Breast Centers</title>
		<imprint>
			<date type="published" when="2014">2014</date>
			<pubPlace>Chicago, IL</pubPlace>
		</imprint>
	</monogr>
	<note>NAPBC Standards Manual 2014 Edition</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Towards quality, comprehensiveness and excellence. The accreditation project of the organisation of European cancer institutes (OECI)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Saghatchian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hummel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Otter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>De Valeriola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Van Harten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Paradiso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Koot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Ringborg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tursz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tumori</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="164" to="171" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE working group</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Capocaccia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Verdecchia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Esteve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gatta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Micheli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Coleman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Berrino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="679" to="683" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Benchmarking the quality of breast cancer care in a nationwide voluntary system: the first five-year results (2003-2007) from Germany as a proof of concept</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Brucker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schumacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rezai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bamberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wallwiener</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Cancer</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">358</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Deutsche</forename><surname>Krebsgesellschaft</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<title level="m" type="main">Catalogue of requirements for Breast Cancer Centres</title>
		<author>
			<persName><forename type="first">Deutsche</forename><surname>Gesellschaft Für Senologie</surname></persName>
		</author>
		<ptr target="http://www.senologie.org/brustzentren/zertififzierungsrichtlinien.2017.https://www.krebsgesellschaft.de/zertdokumente.html" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Quality of care in breast cancer centers: results of benchmarking by the German cancer society and German Society for Breast Diseases</title>
		<author>
			<persName><forename type="first">C</forename><surname>Kowalski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ferencz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Brucker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kreienberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wesselmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Breast</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="118" to="123" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Dreistufenmodell optimiert Behandlung unter Kostendeckung. Wie die künftigen Strukturen der onkologischen Versorgung in Deutschland aussehen sollten</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Beckmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Adler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Albers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bruns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ehninger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hauschild</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Neuhaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Schmiegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Schmoll</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dtsch Arztebl</title>
		<imprint>
			<biblScope unit="volume">04</biblScope>
			<biblScope unit="page" from="A3004" to="3009" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<monogr>
		<title level="m" type="main">Certification Committee Oncology Centres (German Cancer Society and German Cancer Aid): National Cancer Certification Programme. Catalogue of Requirements for Comprehensive Cancer Centres and Oncology Centres</title>
		<imprint>
			<date type="published" when="2015">2015</date>
			<pubPlace>Berlin</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title level="m" type="main">German Guideline Program in Oncology (GGPO) of the German Cancer Society, German Cancer Aid and the Association of the scientific medical societies in Germany Working Group Methodology: Development of guideline based quality indicators. Methods paper for the German Guideline Program in Oncology</title>
		<imprint>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Version 1.0. Berlin</note>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<author>
			<persName><forename type="first">Deutsche</forename><surname>Krebsgesellschaft</surname></persName>
		</author>
		<title level="m">Jahresbericht 2014 der zertifizierten Onkologischen Zentren</title>
				<meeting><address><addrLine>Berlin</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Psycho-oncological care in certified cancer centres-a nationwide analysis in Germany</title>
		<author>
			<persName><forename type="first">S</forename><surname>Singer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dieng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wesselmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychooncology</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1435" to="1437" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Reporting Program A. For cancer care quality indicators</title>
		<author>
			<persName><forename type="first">C</forename><surname>Kowalski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Schulte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wesselmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Oncol Pract</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">President&apos;s plenary international psycho-oncology society: psychosocial care as a human rights issue-challenges and opportunities</title>
		<author>
			<persName><forename type="first">L</forename><surname>Travado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Breitbart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Grassi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fujisawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Patenaude</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Baider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fingeret</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychooncology</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="563" to="569" />
			<date type="published" when="2015">2015. 2017</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
